ARCHIVES

FDA Nearly Wrecks NCI Drug Distribution Program, Finally Agrees To New Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 05 | January 30, 1976

Download PDF Visit The Full Archive

Related Articles

Waxman Introduces NIH Reauthorization, Kennedy To Follow

April 26, 1991

Variation in Breast Density May Be Strong Risk Factor

July 27, 2012

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

Mammography Quality Standards Set, FDA User Fees Enacted; Oral Cancer Drugs Covered

October 16, 1992

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983